Adjuvant endocrine therapy (AET), such as tamoxifen, is often recommended for postmenopausal women for as long as 10 years after completion of breast cancer treatment as a means to limit the risk of cancer recurrence.
from Hindustan Times - lifestyle http://bit.ly/2Gx7ebv
Post Top Ad
Thursday, 18 April 2019
Relationship status influences sexual problems and self-efficacy in breast cancer...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment